Promising CLL Treatments: A Bcl-2 Inhibitor Update

patientpower has 2343 videos Subscribe Here

Description: Dr. John Seymour, a CLL researcher, shares an update about an ongoing trial using the Bcl-2 inhibitor ABT-199, which received a dose modification following safety concerns. Dr. Seymour explains Phase I trial data that demonstrates the therapy's balance of safety and efficacy as well its promising potential for combination with other agents.
Produced in association with CLL Global Research Foundation

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube |
Like on Facebook |
Follow on Twitter |
Shared By : patientpower
Posted on : 02/21/14
Added : 4 years ago
Category : Other